Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial.

Kyu Yong ChoAkinobu NakamuraChiho Oba-YamamotoKazuhisa TsuchidaShingo YanagiyaNaoki MandaYoshio KuriharaShin AokiTatsuya AtsumiHideaki Miyoshi

Published in: Diabetes & metabolism journal (2019)

IDegAsp was more effective than basal insulin at reducing blood glucose after dinner and before bedtime, but did not increase the incidence of hypoglycemia. Switching from basal insulin to IDegAsp does not increase the burden on the patient and positively impacts glycemic control in patients with T2DM.

Keyphrases

glycemic control
blood glucose
type diabetes
randomized controlled trial
weight loss
insulin resistance
risk factors
physical activity
study protocol
metabolic syndrome
blood pressure